Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Article History
First Online: 19 June 2025
Competing interests
: J.S.-R. reports receiving in the last 3 years funding from GSK and Pfizer and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, Grunenthal, Tempus and Moderna.